Breaking News
Close
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

Hikma Pharmaceuticals PLC ADR (HKMPY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
41.6 +0.6    +1.46%
27/06 - Closed. Currency in USD ( Disclaimer )
After Hours
41.8
+0.2
+0.4%
20:54:08 - Delayed Data
  • Volume: 11,360
  • Bid/Ask: 0.0 / 0.0
  • Day's Range: 39.6 - 42.7
Type:  Equity
Market:  United States
ISIN:  US4312881091 
S/N:  431288109
Hikma Pharma ADR 41.6 +0.6 +1.46%
  • General    
  • Chart    
  • News & Analysis    
  • Financials    
  • Technical    
  • Forum    
  • InvestingPro
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2021
31/12
2021
30/06
2020
31/12
2020
30/06
Total Current Assets 2094 1955 1922 1878
Cash and Short Term Investments 450 346 347 436
Cash 155 243 - -
Cash & Equivalents 22 2 323 413
Short Term Investments 273 101 24 23
Total Receivables, Net 811 780 734 671
Accounts Receivables - Trade, Net 719 693 662 560
Total Inventory 695 736 757 684
Prepaid Expenses 65 78 58 66
Other Current Assets, Total 73 15 26 21
Total Assets 4372 4180 4135 3970
Property/Plant/Equipment, Total - Net 1146 1061 1068 970
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 285 286 289 280
Intangibles, Net 607 620 587 570
Long Term Investments 46 36 34 32
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 194 222 235 240
Other Assets, Total - - - -
Total Current Liabilities 1016 960 1028 1070
Accounts Payable 262 226 279 272
Payable/Accrued 468 - 470 -
Accrued Expenses 194 145 175 141
Notes Payable/Short Term Debt 64 132 117 108
Current Port. of LT Debt/Capital Leases 57 49 51 30
Other Current liabilities, Total 439 408 406 519
Total Liabilities 1919 1890 2000 2080
Total Long Term Debt 725 751 764 789
Long Term Debt 651 676 692 730
Capital Lease Obligations 74 75 72 59
Deferred Income Tax 24 21 31 22
Minority Interest 14 13 13 10
Other Liabilities, Total 140 145 164 189
Total Equity 2453 2290 2135 1890
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 42 41 41 41
Additional Paid-In Capital 282 282 282 282
Retained Earnings (Accumulated Deficit) 2353 2197 2011 1814
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -224 -230 -199 -247
Total Liabilities & Shareholders' Equity 4372 4180 4135 3970
Total Common Shares Outstanding 231.5 231.43 230.46 230.41
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HKMPY Comments

Write your thoughts about Hikma Pharmaceuticals PLC ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks you HKMPY. bullish move forward
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Our Apps
DOWNLOAD APPApp store
Investing.com
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
or
Sign up with Email